| Estimated Vaccination Coverage*,† with Selected Vaccines Among Adolescents 13-17 Years of Age§ by Poverty Level¶ and Race/Ethnicity** -- National Immunization Survey-Teen, United States, 2009 |
| Total % (95% CI) | White only, non-Hispanic % (95% CI) | Black only, non-Hispanic % (95% CI) | Hispanic % (95% CI) | American Indian or Alaska Native only, non-Hispanic % (95% CI) | Asian only, non-Hispanic % (95% CI) | ||
|---|---|---|---|---|---|---|---|
| >2 MMR†† | US National | 89.1 (88.3-89.9) | 90.2 (89.3-91.1) | 86.3 (83.6-88.5) | 87.6 (84.9-89.9) | 90.4 (84.1-94.3) | 92.9 (88.5-95.8) |
| At or Above Poverty | 89.3 (88.4-90.2) | 90.4 (89.4-91.4) | 86.9 (83.6-89.5) | 85.4 (81.2-88.8) | 91.7 (85.8-95.3) | 92.1 (86.7-95.4) | |
| Below Poverty | 87.8 (85.5-89.8) | 86.7 (82.3-90.1) | 84.4 (78.9-88.7) | 90.6 (87.0-93.3) | 89.7 (73.1-96.5) | 94.8 (80.6-98.8) | |
| Unknown Poverty | 90.9 (87.5-93.5) | 91.5 (86.7-94.6) | 89.6 (78.9-95.2) | 91.5 (82.5-96.1) | NA | NA | |
| > 3 HepB§§ | US National | 89.9 (89.2-90.6) | 90.2 (89.4-91.0) | 88.9 (86.7-90.8) | 90.0 (87.7-91.9) | 89.7 (83.2-93.9) | 89.5 (83.3-93.6) |
| At or Above Poverty | 90.3 (89.5-91.1) | 90.5 (89.6-91.4) | 89.8 (87.2-92.0) | 89.8 (86.4-92.4) | 91.9 (86.1-95.4) | 91.6 (86.1-95.0) | |
| Below Poverty | 88.3 (86.1-90.1) | 87.4 (83.7-90.3) | 86.6 (81.9-90.3) | 90.3 (86.6-93.0) | 87.1 (69.9-95.1) | 80.2 (56.0-92.8) | |
| Unknown Poverty | 90.0 (86.6-92.7) | 89.3 (84.7-92.7) | 91.8 (81.1-96.7) | 90.3 (80.6-95.4) | NA | NA | |
| > 1 Var¶¶ | US National | 87.0 (85.7-88.2) | 88.5 (87.0-89.8) | 82.4 (78.7-85.7) | 85.5 (81.1-89.0) | 87.9 (76.4-94.2) | 88.1 (79.9-93.2) |
| At or Above Poverty | 87.6 (86.1-88.9) | 88.9 (87.4-90.4) | 82.8 (77.9-86.9) | 85.6 (79.6-90.1) | 84.5 (67.2-93.6) | 87.1 (77.3-93.0) | |
| Below Poverty | 82.9 (79.0-86.3) | 79.3 (72.8-84.6) | 79.8 (73.0-85.2) | 84.6 (76.3-90.4) | 91.7 (76.9-97.3) | NA | |
| Unknown Poverty | 91.4 (86.3-94.7) | 91.3 (84.3-95.4) | 93.7 (86.1-97.3) | 88.6 (73.3-95.6) | NA | NA | |
| > 2 Var*** | US National | 48.6 (46.6-50.6) | 48.8 (46.5-51.2) | 43.9 (39.2-48.6) | 49.7 (44.0-55.5) | 41.0 (26.6-57.1) | 54.2 (41.9-66.0) |
| At or Above Poverty | 48.7 (46.6-50.9) | 49.1 (46.6-51.6) | 44.2 (38.3-50.2) | 49.4 (42.0-56.8) | 37.4 (20.3-58.4) | 54.1 (40.8-66.9) | |
| Below Poverty | 46.2 (41.0-51.5) | 34.2 (27.2-42.0) | 44.4 (36.6-52.4) | 49.7 (40.1-59.3) | 61.8 (36.6-81.9) | NA | |
| Unknown Poverty | 54.0 (44.8-63.0) | 62.4 (52.4-71.4) | NA | 52.3 (30.2-73.6) | NA | NA | |
| > 1 Td or Tdap††† | US National | 76.2 (75.1-77.2) | 76.5 (75.4-77.7) | 72.5 (69.4-75.5) | 76.7 (73.2-79.9) | 78.0 (66.8-86.2) | 84.5 (77.1-89.8) |
| At or Above Poverty | 77.0 (75.8-78.1) | 77.1 (75.8-78.2) | 74.8 (70.9-78.3) | 77.4 (72.9-81.3) | 77.3 (62.3-87.6) | 83.9 (74.9-90.0) | |
| Below Poverty | 71.8 (68.5-74.8) | 68.6 (63.5-73.3) | 69.5 (63.8-74.7) | 74.2 (67.7-79.7) | 83.3 (68.5-92.0) | 87.4 (70.6-95.3) | |
| Unknown Poverty | 77.9 (72.4-82.6) | 79.3 (73.1-84.4) | 63.4 (47.4-76.9) | 83.4 (67.8-92.3) | NA | NA | |
| > 1 Tdap§§§ | US National | 55.6 (54.3-56.8) | 55.8 (54.3-57.2) | 52.7 (49.3-56.1) | 55.6 (51.8-59.4) | 59.3 (48.8-69.1) | 64.3 (55.5-72.3) |
| At or Above Poverty | 56.1 (54.7-57.5) | 56.1 (54.6-57.7) | 55.6 (51.4-59.8) | 54.8 (49.8-59.6) | 57.6 (44.1-70.0) | 62.2 (52.2-71.4) | |
| Below Poverty | 52.8 (49.3-56.3) | 49.5 (43.9-55.1) | 47.7 (41.6-53.8) | 55.8 (49.2-62.1) | 64.1 (48.1-77.5) | 77.3 (59.2-88.9) | |
| Unknown Poverty | 56.8 (50.6-62.9) | 58.8 (51.4-65.9) | 47.8 (33.6-62.3) | 62.3 (46.3-76.0) | NA | NA | |
| > 1 MenACWY¶¶¶ | US National | 53.6 (52.4-54.9) | 53.1 (51.7-54.5) | 53.0 (49.6-56.4) | 55.9 (52.0-59.7) | 46.9 (37.3-56.8) | 58.8 (49.6-67.4) |
| At or Above Poverty | 53.8 (52.4-55.2) | 53.3 (51.8-54.8) | 53.8 (49.6-58.0) | 55.9 (50.9-60.7) | 48.4 (36.0-61.0) | 60.7 (50.5-70.0) | |
| Below Poverty | 52.5 (49.0-55.9) | 47.1 (41.5-52.8) | 52.0 (45.9-58.0) | 56.2 (49.7-62.6) | 50.8 (35.5-66.0) | 49.1 (27.1-71.4) | |
| Unknown Poverty | 55.4 (49.1-61.6) | 58.7 (51.5-65.6) | 49.3 (34.9-63.8) | 53.9 (37.6-69.5) | NA | NA | |
| > 1 HPV**** | US National | 44.3 (42.4-46.1) | 43.9 (41.8-46.1) | 44.6 (39.9-49.5) | 45.5 (40.3-50.8) | 52.3 (39.0-65.2) | 41.5 (29.5-54.5) |
| At or Above Poverty | 42.5 (40.5-44.5) | 43.0 (40.8-45.3) | 40.7 (34.9-46.8) | 42.0 (35.6-48.7) | 45.9 (30.5-62.1) | 44.9 (30.9-59.9) | |
| Below Poverty | 51.9 (47.0-56.8) | 52.5 (44.1-60.6) | 51.6 (43.2-59.9) | 52.2 (43.2-61.1) | 68.3 (48.1-83.4) | NA | |
| Unknown Poverty | 46.4 (37.5-55.5) | 48.3 (38.2-58.6) | 51.2 (30.6-71.3) | 44.3 (24.1-66.6) | NA | NA |
| * Estimate presented as point estimate (%) ± 95% confidence interval (CI). Estimate=NA (Not Available) if the unweighted sample size | ||||||||||||
| for the denominator was <30 or (CI half width)/Estimate > 0.6. | ||||||||||||
| † Estimates with confidence intervals >20 may not be reliable. | ||||||||||||
| § Adolescents in the 2009 NIS-Teen were born during January 1991-February 1997. | ||||||||||||
| Vaccination coverage estimates include only adolescents who had adequately complete provider-reported immunization records. | ||||||||||||
| National estimates do not include adolescents living in the U.S. Virgin Islands (i.e., St. Croix, St. Thomas, St. John, and Water Island) (n=333). | ||||||||||||
| ¶ Based on family income and household size using US Bureau of Census poverty thresholds for 2008. | ||||||||||||
| ** Reported by respondent. Adolescents identified as White, Black, American Indian/Alaska Native, Asian, or Native Hawaiian/Pacific Islander are all non-Hispanic. | ||||||||||||
| Adolescents of Hispanic ethnicity may be of any race. Reported by respondent. | ||||||||||||
| †† > 2 doses of measles-mumps-rubella vaccine | ||||||||||||
| §§ >3 doses of hepatitis B vaccine. | ||||||||||||
| ¶¶ > 1 dose of varicella vaccine among adolescents without a history of varicella disease. | ||||||||||||
| *** > 2 doses of varicella vaccine among adolescents without a history of varicella disease. | ||||||||||||
| ††† > 1 dose of tetanus toxoid-diphtheria vaccine (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years. | ||||||||||||
| §§§ > 1 dose tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years. | ||||||||||||
| ¶¶¶ >1 meningococcal conjugate vaccine or meningococcal -unknown type vaccine. | ||||||||||||
| **** >1 human papillomavirus vaccine, either quadrivalent or bivalent. Percentages reported among females only. | ||||||||||||
| tab16_race_pov2 | ||||||||||